Seroepidemiological study of Epstein-Barr virus infection in Bangladesh

Journal of Medical Virology

Volumn 48, Issue 1, 1996, Pages 17-21

  Haque, T ^a   Iliadou, P ^a   Hossain, A ^b   Crawford, D H ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b ICDDRB Laboratory Sciences Division   (Bangladesh)

Author keywords

anti VCA IgG antibody; ELISA; Epstein Barr virus; Immunofluorescence; Seroepidemiology

Indexed keywords

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; BANGLADESH; BLOOD ANALYSIS; CHILD; CLINICAL TRIAL; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIOLOGY; EPSTEIN BARR VIRUS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; INFANT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; TECHNIQUE; VIRUS INFECTION;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; BANGLADESH; CAPSID; CHILD; CHILD, PRESCHOOL; DIARRHEA; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOGLOBULIN G; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; PREVALENCE; REAGENT KITS, DIAGNOSTIC; TUMOR VIRUS INFECTIONS;

EID: 0030002397     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(199601)48:1<17::AID-JMV3>3.0.CO;2-O     Document Type: Article

References (25)

1. Biggar R, Henle W, Fleisher G, Bocker J, Lennettte ET, Heule G (1978): Primary Epstein-Barr virus infections in African infants. I: Decline of maternal antibodies and time of infection. International Journal of Cancer 22:239-243.
2. Black FL, Hierholzer WJ, Pinheiro De P (1974): Evidence of persistence of infectious agents in isolated human populations. American Journal of Epidemiology 100:230-250.
3. Davidson I, Stern K, Kashiwagi C (1971): The differential tests for infectious mononucleosis. American Journal of Clinical Pathology 21:1101-1113.
4. Dolken G, Weitzmann U, Boldt C, Bitzer M, Brugger W, Lohr GW (1984): Enzyme-linked Immunosorbent Assay for IgG antibodies to Epstein-Barr virus-associated early antigens and viral capsid antigen. Journal of Immunology Methods 67:225-233.
5. Evans AS 91982): Epidemiology of Epstein-Barr virus infection and disease. In Nahmias AJ, Doudle W, Sehinazi R (eds) "The Human Herpes Virus." Amsterdam: Elsevier North Holland, pp. 172-183.
6. Golden HD, Chang RS, Prescott W, Simpson E and Cooper TY (1973): Leukocyte-transforming agent: prolonged excretion by patients with mononucleosis and excretion by normal individuals. Journal of Infectious Diseases 127:471-473.
7. Golubjatnikov R, Allen VD, Steadman M, Olmos Blancarte MP, Inhorn SL (1973): Prevalence of antibodies to Epstein-Barr virus, cytomegalovirus and toxoplasma in a Mexican highland community. American Journal of Epidemiology 97:116-124.
8. Heath CW, Brodsky AL, Potolsky AL (1972): Infectious mononucleosis in general population. American Journal of Epidemiology 95: 46-52
9. Henle G, Henle W (1966): Immunofluorescence in cells derived from Burkitt lymphoma. Journal of Bacteriology 91:1248-1256.
10. Henle W, Henle G, Horowitz CA (1974): Epstein-Barr virus specific diagnostic tests in infectious mononucleosis. Human Pathology 5:551-565.
11. Hossain A (1987): Seroepidemiology of Epstein-Barr virus infections in a developing country. Journal of Tropical Pediatrics 33:257-260
12. Hotchin NA, Crawford DH (1991): The diagnosis of Epstein-Barr virus-associated disease. In Morgan-Capner P. (ed): "Current Topics in Clinical Virology." London: Laversham Press; pp 115-140.
13. Kafuko GW, Henderson BE, Kirya BG (1972): Epstein-Barr virus antibody levels in children from West Nile District of Uganda. Lancet 1:706-709.
14. Klein G, Clifford P, Klein E (1967): Membrane immunofluorescence reactions of Burkitt lymphoma cells from biopsy specimens and tissue cultures. Journal of the National Cancer Institute 39:1027-1044.
15. Klein G, Svedmyr E, Jondal U, Persson PO (1976): EBV-determined nuclear antigen (EBNA) positive cells in the peripheral blood of infectious mononucleosis patients. International Journal of Cancer 17:21-26.
16. Lang DJ, Garruto RM, Gajdusek DC (1977): Early acquisition of cytomegalovirus and Epstein-Barr virus antibody in several isolated Melanesian populations. American Journal of Epidemiology 105(5):480-487.
17. Luby JP, Shasby DM (1972): A sex difference in the prevalence of antibodies to cytomegalovirus. Journal of the American Medical Association 203:1290-1291.
18. Luka J, Chase RC, Pearson GR (1984): A sensitive Enzyme-linked Immunosorbent Assay (ELISA) against the major EBV-associated antigens. Journal of Immunology Methods 67:145-156.
19. Michaels RH, Rogers KD (1971): A sex difference in immunologic responsiveness. Pediatrics 47:120-123.
20. Niederman JC, Evans AS, Subramanyan L and McCollum RW (1970): Prevalence, incidence and persistence of EB virus antibody in young adults. New England Journal of Medicine 282:361-365.
21. Porter DD, Wimberly I, Benyesh-Melnick M (1969): Prevalence of antibodies to EB virus and other herpes viruses. Journal of the American Medical Association 208:1675-1679
22. Sumaya CV, Henle W, Henle G, Smith MH, LeBlanc D (1975): Seroepidemiologic study of Epstein-Barr virus infections in a rural community. Journal of Infectious Disease 131:403-407.
23. Thiele G, Bicak M, Grierson H, Lai P, Purtillo DT (1987): Antibody reactivity to a synthetic peptide (P62) of the Epstein-Barr nuclear antigen in sera of patients with X-linked lymphoproliferative syndrome. Journal of Immunology Methods 100:249-259.
24. Tischendorf P, Balagtas RC, Deinhardt F (1970): Development and persistence of immunity to Epstein-Barr virus in man. Journal of Infectious Diseases 122:401-409.
25. Tsega E, Mengesha B, Hansson BG, Nordenfelt E, Lindberg J (1987): Serological and demographic survey of Epstein-Barr virus infection in Ethiopia. Transections of Royal Society of Tropical Medicine and Hygiene 81:677-680.